HOE-498

Known as: HOE 498, HOE498 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1984-1990
051019841990

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1986
1986
The effects of the angiotensin converting enzyme (ACE) inhibitors captopril, enalapril, HOE 498, and its prodrug on reperfusion… (More)
Is this relevant?
1986
1986
The novel prodrug-converting-enzyme (CE) inhibitor perindopril (S9490-3) diacid was found to be as potent as ramipril (Hoe498… (More)
Is this relevant?
1986
1986
The spontaneously hypertensive rat (SHR) has many characteristics indicative of an overactive brain-angiotensin system. Since… (More)
Is this relevant?
1985
1985
Inhibition of angiotensin II generation in the plasma does not fully explain the antihypertensive effects of converting enzyme… (More)
Is this relevant?
1985
1985
The role of converting enzyme (CE) in heart function was studied by assessing the inhibition of CE activity in rat heart tissue… (More)
Is this relevant?
1985
1985
The converting enzyme inhibitor HOE 498 was evaluated in 12 normotensive male volunteers aged 21 to 26. The efficacy of single 5… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
1985
1985
The effect of different oral doses of HOE 498, a new non-sulphydryl containing converting enzyme inhibitor, was investigated in a… (More)
Is this relevant?
1984
1984
The mechanism of antihypertensive action of converting enzyme (CE) inhibitors was studied by comparing two compounds of different… (More)
Is this relevant?
1984
1984
The cardiovascular and antihypertensive activities of the novel orally active non-sulfhydryl converting enzyme (CE) inhibitor 2… (More)
Is this relevant?
1984
1984
2-[N-[(S)-1-Ethoxycarbonyl-3-phenylpropyl]-L-alanyl] - (1S,3S,5S) -2-azabicyclo [3.3.0] octane-3-carboxylic acid (Hoe 498) is a… (More)
Is this relevant?